Magnetic resonance imaging pattern in natalizumab‐associated progressive multifocal leukoencephalopathy

Tarek Yousry; Daniel Pelletier; Diego Cadavid; Achim Gass; Nancy Richert; Ernst‐Wilhelm Radue; Massimo Filippi

doi:10.1002/ana.23676

Back

Magnetic resonance imaging pattern in natalizumab‐associated progressive multifocal leukoencephalopathy

Article 2012 en

Abstract

1 min read

Attention to characteristic MRI patterns, especially the presence of contrast enhancement, and the subcortical location may have utility in screening and early diagnosis of PML in natalizumab-treated MS patients.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1998

Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis.

Franz Fazekas, Frederik Barkhof, Massimo Filippi

Article1998

Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis.

Franz Fazekas, Frederik Barkhof, Massimo Filippi

Article2004

Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis

David H. Miller, Massimo Filippi, Franz Fazekas, Jette Lautrup Frederiksen, Paul M. Matthews, Xavier Montalbán, Chris H. Polman

Article2015

The Effects of Natalizumab and Fingolimod on Clinical, Neuropsychological and MRI Measures in Relapsing Remitting Multiple Sclerosis: A One-Year Comparative Study (P6.152)

Paolo Preziosa, Maria A. Rocca, Gianna Carla Riccitelli, Mariaemma Rodegher, Massimiliano Copetti, Lucia Moiola, Francesco Mele, Andrea Falini, Giancarlo Comi, Massimo Filippi

Article2012

New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis

Massimo Filippi, Maria A. Rocca